ClinConnect ClinConnect Logo
Search / Trial NCT05299619

Tixel Treatment for Dry Eye Symptoms

Launched by DR LUDGER HANNEKEN · Mar 28, 2022

Trial Information

Current as of May 14, 2025

Completed

Keywords

ClinConnect Summary

Tixel® (Novoxel®, Israel) is a thermomechanical system developed for fractional treatment. The system is designed for the treatment of soft tissue by direct conduction of heat, enabling fast water evaporation with low thermal damage to the surrounding tissue (such as charring or ablation). The system consists of a handpiece connected to a console. The handpiece applies a therapeutic element, the "tip", fixated on the distal section. The tip is comprised of a gold-plated copper base and a thin-walled titanium alloy cover.

While treating patients for wrinkles, it has been observed that in se...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. ≥ 18 years
  • 2. Mild to Moderate Periorbital wrinkles
  • 3. OSDI score of at least 23
  • 4. Noninvasive Tear film break up time (NIKBUT) ≤ 10 seconds
  • 5. Willing and able to provide written informed consent.
  • 6. Willing to participate in all study activities and instructions.
  • Exclusion Criteria:
  • 1. Pregnancy and breastfeeding
  • 2. Lesions in the periorbital area
  • 3. Acute severe blepharitis
  • 4. Acute conjunctivitis
  • 5. Other concomitant anterior eye disease

About Dr Ludger Hanneken

Dr. Ludger Hanneken is a distinguished clinical trial sponsor with extensive expertise in the field of medical research and development. With a strong commitment to advancing healthcare through innovative clinical studies, Dr. Hanneken leads initiatives that focus on the evaluation of novel therapies and treatment methodologies. His collaborative approach fosters partnerships with leading research institutions and healthcare professionals, ensuring rigorous study design and adherence to regulatory standards. Driven by a passion for improving patient outcomes, Dr. Hanneken’s work contributes significantly to the scientific community and the advancement of evidence-based medicine.

Locations

Escaldes Engordany, , Andorra

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials